drugset / Trial / NCT04110145
Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this study is to evaluate the dose response, safety, and efficacy of linaclotide when compared with placebo in pediatric participants, 2 to 5 years of age, with Functional Constipation.
Timeline
- Start
- 2019-10-14
- Primary completion
- 2021-04-20
- Completion
- 2021-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linaclotide | Peptide | 18 ug | Oral |
| Subject | Linaclotide | Peptide | 36 ug | Oral |
| Subject | Linaclotide | Peptide | 72 ug | Oral |